Keyphrases
Sensitivity to Chemotherapy
100%
Phosphatase
100%
Cholangiocarcinoma
100%
Yes-associated Protein 1 (YAP1)
100%
SHP2
100%
Co-activity
100%
Chemoresistance
27%
Gemcitabine
18%
Protein Activity
18%
Cisplatin
18%
Genomic Deletion
18%
Myeloid Cell leukemia-1 (Mcl-1)
18%
Protein Tyrosine Phosphatase 1B (PTP1B)
18%
Phosphatase Activity
18%
Tumor
9%
Phosphorylation
9%
Pharmacological Inhibitors
9%
Anti-apoptotic
9%
Chemotherapy Resistance
9%
Tumor Subtype
9%
Sequence Data
9%
Xenograft
9%
Chemotherapy Sensitivity
9%
Chemosensitivity
9%
Protein Targeting
9%
Cholangiocarcinoma Cell Line
9%
Hippo Pathway
9%
In Vivo Evaluation
9%
Normal Liver
9%
Cholangiocarcinoma Cells
9%
Transcriptionally Active
9%
Human Cholangiocarcinoma
9%
BRAF Inhibition
9%
Mcl-1 Inhibitor
9%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
100%
Phosphatase
100%
MCL1
100%
Gemcitabine
66%
Cisplatin
66%
Gene Deletion
66%
Protein Tyrosine Phosphatase
66%
KRAS
33%
Chemosensitivity
33%
Medicine and Dentistry
Cholangiocarcinoma
100%
Protein Tyrosine Phosphatase SHP 2
100%
Drug Resistance
50%
Neoplasm
33%
Gemcitabine
33%
Cisplatin
33%
Gene Deletion
33%
Protein Tyrosine Phosphatase
33%
Malignant Neoplasm
16%
Cell Line
16%
Antiapoptotic
16%
Xenograft
16%
Target Protein
16%
Phosphatase
16%
Cholangiocarcinoma Cell Line
16%
Chemosensitivity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Bile Duct Carcinoma
100%
Protein Tyrosine Phosphatase SHP 2
100%
Drug Resistance
42%
Neoplasm
28%
Gemcitabine
28%
Cisplatin
28%
Protein Tyrosine Phosphatase
28%
Malignant Neoplasm
14%
Antiapoptotic
14%
Phosphatase
14%